JAPAN TOBACCO (2914) FY2026 Q2 Earnings Report

Quick View

Executive Summary

The key takeaway for Q2 of the fiscal year ending December 2026 was the acceleration of revenue and profit growth, driven by improved pricing and product mix in the Tobacco Business and favorable foreign exchange movements, resulting in an upward revision to the full-year forecast. Revenue was ¥19,860.7B (¥16,867.9B in the year-ago period, +17.7%), while Operating Income was ¥6,449.4B (¥5,001.3B, +29.0%), with the profit growth rate exceeding the revenue growth rate. Net Income was ¥4,331.8B (+34.5%), of which Net Income attributable to owners of the parent was ¥4,318.3B (+35.0%). The Operating Income margin improved by +2.8pt year on year to 32.5%, and progress toward the full-year Operating Income forecast of ¥10,080B was 64.0%, substantially ahead of the 50% half-year benchmark.

Factors Affecting Results

【Revenue】Revenue of ¥19,860.7B (+17.7%) was driven by higher revenue from the Tobacco Business, which accounted for 95.9% of the composition and generated ¥19,055.9B (+18.4%). In addition to price revisions and mix improvement, increased volumes of RRP (reduced-risk products), including Ploom, and favorable foreign exchange movements contributed to growth. Revenue from the Processed Foods Business increased modestly to ¥792.4B (+3.2%), supported by price revisions in the frozen-food and shelf-stable businesses.

【Profit and Loss】Operating Income of ¥6,449.4B (+29.0%) grew faster than revenue, reflecting operating leverage. The gross margin was 58.9% (57.6% in the year-ago period, +1.3pt), while the SG&A expense ratio was 27.1% (28.8% in the year-ago period, -1.6pt). Profit Before Tax was ¥6,060.0B (+32.4%). Although the effective tax rate increased to 28.5% from 26.6% in the year-ago period, the growth in Profit Before Tax more than offset the increase, resulting in Net Income growth of +34.5% (+35.0% for the portion attributable to owners of the parent). In addition, impairment losses amounted to ¥251.8B in the year-ago period, compared with only ¥10.4B in the current period, acting as a one-time factor that amplified profit growth. Overall, the company achieved higher revenue and profits, with price-led operating leverage driving earnings growth.

Segment Analysis

The core business is the Tobacco Business, which generated revenue of ¥19,055.9B (95.9% of the total, +18.4%) and Operating Income of ¥6,829.0B (+25.3%), with a profit margin of 35.8%, making it the central contributor to company-wide profits. The Processed Foods Business generated revenue of ¥792.4B (+3.2%) and Operating Income of ¥40.7B (+58.5%), with a profit margin of 5.1%. Although its profit growth rate was high due to the effects of price revisions, its contribution in absolute profit terms was limited. Other segments generated revenue of ¥12.4B (-1.7%) and recorded Operating Income of -¥252.7B, reflecting the burden of company-wide expenses and other costs. The gap in profit margins between the segments is substantial (35.8% for Tobacco versus 5.1% for Processed Foods), and the primary driver of performance fluctuations was the pricing and mix effect in the Tobacco Business.

Key Financial Metrics

Profitability: ROE 9.8% (7.8% in the year-ago period, +2.0pt), Operating Income margin 32.5% (29.7% in the year-ago period, +2.8pt)
Cash flow quality: Operating CF / Net Income 0.77x (cash generation has not kept pace with Net Income growth year on year, remaining below 1.0x), FCF ¥2,729.1B
Financial soundness: Equity Ratio 50.7% (48.5% in the year-ago period, +2.2pt), Current Ratio approximately 2.04x (current assets ¥38,531.2B / estimated current liabilities ¥18,848.4B)

Cash Flow Analysis

Operating CF was ¥3,313.3B, a substantial increase of +97.9% year on year, but stood at only 0.77x Net Income. In terms of working capital, an increase in trade receivables (-¥1,005.6B), a decrease in trade payables (-¥829.7B), and higher corporate income tax payments (-¥1,356.7B) were negative factors. Investing CF was -¥584.2B, primarily due to capital expenditures of ¥532.3B. Financing CF was -¥2,782.4B, mainly reflecting dividend payments of ¥2,307.2B, while share repurchases were minimal at ¥8.6B. FCF (Operating CF plus Investing CF) was ¥2,729.1B, nearly sufficient to cover dividend payments. Cash generation is assessed as “standard to requiring monitoring,” as increased working capital has slowed cash conversion relative to earnings growth.

Quality of Earnings

As the company applies IFRS, there is no concept of Ordinary Income; therefore, Profit Before Tax of ¥6,060.0B is compared with Net Income of ¥4,331.8B (¥4,318.3B attributable to owners of the parent). The difference between the two is primarily attributable to income taxes of ¥1,728.2B (an effective tax rate of 28.5%, up from 26.6% in the year-ago period), and no significant divergence due to temporary extraordinary gains or losses is evident. Financial income of ¥386.4B was offset by financial expenses of ¥775.8B, resulting in a net cost of approximately ¥389.4B (approximately 2.0% of revenue), which was more than absorbed by the increase in Operating Income. Impairment losses recorded in the year-ago period amounted to ¥251.8B, compared with ¥10.4B in the current period, representing a temporary comparative factor that should be considered when assessing the current period’s profit growth rate. Operating CF was below Net Income, confirming a delay in cash conversion attributable to increased working capital from an accrual perspective.

Earnings Forecast and Guidance

Progress toward the full-year forecasts of revenue of ¥38,850B and Operating Income of ¥10,080B was 51.1% for revenue, 64.0% for Operating Income, and 67.0% for Net Income attributable to owners of the parent (against the forecast of ¥6,440B). Operating Income and Net Income are therefore progressing 14–17pt ahead of the standard H1 benchmark of 50%, indicating an accelerated pace. The full-year forecast has already been revised upward, primarily due to pricing effects in the Tobacco Business exceeding expectations and improving foreign exchange conditions, with the full-year foreign exchange impact revised from an initially projected -¥90B to an expected +¥470B. The annual dividend forecast has also been revised to ¥272, including the interim dividend of ¥136, representing a ¥30 increase.

Shareholder Returns

An interim dividend of ¥136 was recorded, and the company forecasts a full-year dividend of ¥272, an increase of ¥30 from the previous fiscal year. The Payout Ratio is 75.2% based on the company’s disclosure, calculated using adjusted Net Income of ¥6,420B after adjustments related to litigation settlement payments. Share repurchases were small at ¥8.6B, making dividends the primary form of shareholder returns. Even including share repurchases, the impact on total shareholder returns is limited, and the Total Return Ratio remains effectively close to the Payout Ratio.

Catalysts

【Short Term】Progress on price revisions in the second half, trends in market share expansion for RRP products such as Ploom, the impact of accounting adjustments in hyperinflationary countries, and changes in foreign exchange trends will affect quarterly performance.

【Long Term】Trends in tobacco regulations and tax tightening in each country, developments in smoking-related litigation, responses to declining Combustibles demand, and the results of strategic investment in RRP will affect the earnings structure over the medium to long term.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (food_beverage)

Profitability and Returns

The company’s Operating Income margin and Net Income margin are considered to be at high levels within the industry.

Growth and Capital Efficiency

Revenue growth was also in the double digits, indicating solid growth within the industry.

※Source: Compiled by the company

Risk Factors

1. Goodwill dependence: Goodwill of ¥29,867.1B represents 34.4% of total assets and 67.5% of net assets of ¥44,230.5B. Sensitivity to impairment testing in the event of tighter regulations or changes in market conditions is relatively high.

2. Increase in working capital and cash conversion: Operating CF / Net Income remained at 0.77x, with trade receivables increasing by +¥1,130.7B (+17.7%), trade payables decreasing by -¥882.1B (-12.4%), and higher corporate income tax payments (-¥1,356.7B) acting as negative factors. A lag in cash generation relative to earnings growth has been identified.

3. Regulatory and litigation environment: Payments of settlement amounts related to smoking-related litigation, including cases naming Canadian subsidiary JTI-Macdonald Corp. as a defendant, are explicitly identified as adjustment items in calculating the Payout Ratio. This creates a structure in which regulatory and litigation developments affect both earnings and shareholder returns.

Key Earnings Highlights

1. Progress toward the full-year forecasts reached 64.0% for Operating Income and 67.0% for Net Income attributable to owners of the parent, substantially exceeding the standard 50% benchmark. Both the full-year earnings forecast and dividend forecast were revised upward. The fact that price-led profit growth is progressing ahead of the company’s plan is noteworthy.

2. The improvement of +1.3pt in the gross margin and +2.8pt in the Operating Income margin indicates a structural improvement in profitability driven by pricing and mix effects in the Tobacco Business. At the same time, Operating CF / Net Income of 0.77x suggests a gap between earnings growth and cash generation.

3. Goodwill representing 67.5% of net assets is a capital structure based on an M&A-derived growth platform. However, it also relatively reduces the financial cushion in the event of changes in the external environment and will be a monitoring point going forward.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥2,949–¥3,125 at ±1% for the cost of equity, and ¥3,021–¥3,057 at ±0.1 for ω.

Notes:

• Because Net Income progress toward the full-year forecast (67%) exceeds the standard level (50%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies progressing ahead of their forecasts tend to exceed those forecasts; adjustments may be excessive for businesses with strong seasonality).
• The ratio of goodwill to net assets is high, and the assumptions would change substantially if impairment were recognized.
• Net assets as of the quarter-end are used (there is a timing difference versus the full-year forecast).

(Calculation model: Residual income model / Interest rate reference month: 2026-06 / This figure does not predict or guarantee future share prices)

---

This report is an earnings analysis document automatically generated by AI through integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

JT delivered a strong FY2026 Q2 result, with revenue, operating income, and profit attributable to owners all growing at double-digit rates. Revenue increased 17.7% year on year to ¥1,986.1bn. Operating income rose 29.0% to ¥644.9bn, materially outpacing sales growth. Profit attributable to owners increased 35.0% to ¥431.8bn, and basic EPS rose to ¥243.24 from ¥180.19. Gross profit expanded 20.4% to ¥1,170.0bn. The gross margin improved by 130bp to 58.9%, indicating favorable pricing, mix, and/or cost absorption. The operating margin increased by 282bp to 32.5% from 29.6%. SG&A expense grew 11.2%, well below revenue growth, reducing the SG&A-to-sales ratio by 160bp to 27.1% and demonstrating positive operating leverage. Net margin expanded by 283bp to 21.7%. The annualized ROE was 19.5%, an excellent level supported by strong margins and moderate financial leverage. Annualized ROA was approximately 10.1%, based on annualized first-half net income and average assets, also indicating high asset-level profitability. However, operating cash flow of ¥331.3bn was only 0.77x net income, below the 0.8x earnings-quality threshold. Receivables, inventories, and payables movements absorbed ¥208.8bn in cash, while other working-capital changes absorbed a further ¥35.7bn. Free cash flow remained positive at ¥272.9bn and exceeded first-half cash dividends of ¥230.7bn, but the coverage cushion was limited. Goodwill of ¥2,986.7bn equals 67.5% of equity and remains a material balance-sheet sensitivity despite the strong operating performance. The full-year forecast implies first-half progress of 51.1% for revenue, 64.0% for operating income, and 67.1% for profit attributable to owners, with the latter two materially ahead of the standard 50% first-half run rate. The revised FY2026 dividend forecast of ¥272 per share implies a 75.0% payout against forecast EPS of ¥362.74, while management cites a 75.2% payout based on adjusted profit after the impact of the Canadian litigation settlement payment adjustment. The central forward implication is that profit delivery is ahead of plan, but cash conversion, working-capital normalization, litigation-related cash obligations, and preservation of acquired-business value will determine the durability of shareholder distributions and returns.

Profitability Analysis

The DuPont decomposition shows annualized ROE of 19.5%, comprising a 21.7% net profit margin, 0.458x annualized asset turnover, and 1.96x financial leverage. Margin is the principal source of the high return profile: the 21.7% net margin is well above the 10% benchmark for excellent profitability, while asset turnover is modest because the asset base includes substantial goodwill and other long-lived assets. Financial leverage is meaningful but not aggressive, with a reported debt-to-equity ratio of 0.96x and an equity ratio of 50.7%. The largest year-on-year improvement was operating profitability, with operating income growing 29.0% versus 17.7% revenue growth and the operating margin expanding 282bp to 32.5%. Gross margin rose 130bp to 58.9%, while SG&A grew only 11.2%, versus 17.7% sales growth, creating favorable operating leverage. The SG&A ratio consequently declined to 27.1% from 28.8%. The five-factor DuPont bridge shows a tax burden of 0.713, consistent with a 28.5% effective tax rate, and an interest burden of 0.940, indicating that the net finance-cost burden reduced EBIT-to-pre-tax-profit conversion but did not materially impair profitability. Finance costs of ¥77.6bn exceeded finance income of ¥38.6bn, producing a ¥38.9bn net finance cost. The margin expansion appears operationally constructive because it was accompanied by slower SG&A growth rather than relying solely on below-the-line items. Nevertheless, the sustainability of reported margins should be assessed against management's currency-constant adjusted operating-income framework, which excludes acquisition-related intangible amortization, restructuring items, goodwill impairment, and the Canadian annual settlement adjustment.

Growth Assessment

First-half revenue growth of 17.7% and operating-income growth of 29.0% indicate strong earnings momentum. Profit attributable to owners grew faster still, at 35.0%, supported by operating-margin expansion and the absence of the prior-year discontinued-operations loss that weighed on reported earnings. The FY2026 forecast calls for revenue of ¥3,885.0bn, operating income of ¥1,008.0bn, and profit attributable to owners of ¥644.0bn. First-half revenue progress of 51.1% is broadly in line with the standard 50% first-half benchmark. Operating-income progress of 64.0% is 14.0 percentage points ahead of the benchmark, and profit-attributable-to-owners progress of 67.1% is 17.1 percentage points ahead. This front-loaded earnings profile provides scope for the upgraded outlook but also sets a demanding comparison base for the second half. Management's stated medium- to long-term target is mid- to high-single-digit annual growth in constant-currency adjusted operating income. Accordingly, reported yen growth should be interpreted alongside currency-constant performance, inflation adjustments in selected markets, and the durability of tobacco pricing and product mix. The 2/10 consistency score indicates that the available multi-period growth pattern has not been consistently smooth, despite the currently stable margin trend.

Financial Health

Financial health is supported by a 50.7% equity ratio, up from 48.5% a year earlier, and total equity increased ¥307.7bn year on year to ¥4,423.1bn. The current ratio is approximately 2.04x, based on current assets of ¥3,853.1bn and estimated current liabilities of ¥1,884.8bn, and therefore does not indicate a near-term liquidity shortfall. Cash and cash equivalents were ¥827.9bn, while trade receivables were ¥753.7bn and current financial assets were ¥205.4bn. The quick ratio is approximately 0.95x before considering other liquid current assets, which makes timely receivable collection and cash management relevant. Bonds and borrowings totaled ¥1,676.8bn, including ¥117.1bn current and ¥1,559.7bn non-current, so only a limited portion of reported borrowings matures within one year. This debt structure reduces maturity-mismatch risk relative to the current asset base. The reported debt-to-equity ratio of 0.96x is below the 2.0x aggressive-leverage warning threshold. Net defined-benefit liabilities of ¥250.0bn and non-current provisions of ¥61.0bn are additional long-term obligations to monitor. Goodwill represents 34.4% of total assets and 67.5% of equity, leaving book equity materially dependent on continued value realization from acquired businesses. The Canadian smoking-and-health litigation settlement payment arrangement is a significant contingent cash-flow and execution consideration reflected in management's adjusted-profit and dividend framework.

Notable B/S Changes

Trade receivables: +¥113.1bn (+17.6%) year on year to ¥753.7bn - supports reported sales growth but contributed ¥100.6bn to first-half operating cash outflow and is consistent with the 69-day DSO alert. Inventories: +¥58.6bn (+5.5%) year on year to ¥1,118.8bn - increased inventory investment contributed ¥25.3bn to first-half operating cash outflow; the reported 250-day DIO warrants close monitoring. Goodwill: +¥64.5bn (+2.2%) year on year to ¥2,986.7bn - the absolute increase exceeds ¥50bn and reinforces already high goodwill concentration of 67.5% of equity, increasing impairment sensitivity. Total equity: +¥307.7bn (+7.5%) year on year to ¥4,423.1bn - retained profit and positive comprehensive income strengthened the equity ratio by 220bp to 50.7%.

Cash Flow Quality

Operating cash flow was ¥331.3bn, up substantially from ¥167.5bn in the prior-year first half, but it remained below net income of ¥431.8bn. The 0.77x OCF-to-net-income ratio is below the 0.8x quality threshold and is therefore a potential earnings-cash conversion concern. The accruals ratio of 1.2% remains low and does not itself indicate elevated accrual risk. Working capital was a major use of cash: receivables absorbed ¥100.6bn, inventories absorbed ¥25.3bn, payables absorbed ¥83.0bn, and other working-capital movements absorbed ¥35.7bn. The simultaneous cash outflow from receivables, inventory, and payables signals that growth has required material working-capital funding rather than being fully self-financing in the period. Reported DSO of 69 days exceeds the 60-day alert threshold, increasing exposure to collection timing and customer-credit risk. Reported DIO of 250 days exceeds both the 90-day general warning threshold and the 60-day processed-goods benchmark, pointing to a high inventory commitment and potential inventory valuation or obsolescence sensitivity. The reported cash conversion cycle of 180 days also exceeds the 120-day warning level, indicating a structurally long cash-to-cash cycle. These working-capital indicators are particularly important because cash conversion is below net-income conversion despite strong accounting earnings. Capital expenditures were ¥53.2bn and intangible-asset purchases were ¥7.2bn, while investing cash outflow was ¥58.4bn. Free cash flow was therefore positive at ¥272.9bn, equivalent to 82.4% of operating cash flow. The company funded ¥230.7bn of dividends and ¥0.9bn of share repurchases during the first half, leaving only a modest free-cash-flow surplus after shareholder distributions.

Dividend Sustainability

The FY2026 dividend forecast is ¥272 per share, of which ¥136 per share has been indicated for the interim payment. The forecast dividend represents a 75.0% payout ratio against forecast EPS of ¥362.74. Management separately states a 75.2% payout ratio based on adjusted FY2026 profit of ¥642.0bn after adjustments related to the Canadian litigation settlement payment and related effects. The first-half cash dividend payment of ¥230.7bn was covered by free cash flow of ¥272.9bn, or approximately 1.18x coverage. This supports interim distribution capacity, although the free-cash-flow cushion was not wide. The calculated first-half dividend payout ratio of 63.0% is below the full-year target range implied by the forecast, reflecting the timing of earnings and the semiannual dividend structure. Share repurchases were immaterial at ¥0.9bn, so the total return ratio was close to the dividend payout ratio in the period. Dividend sustainability is underpinned by high operating margins and positive free cash flow, but cash conversion below net income, elevated working-capital requirements, and litigation-related payments constrain flexibility. Future dividend capacity will depend on the conversion of receivable and inventory investment back into cash, as well as continued achievement of management's adjusted-profit assumptions.

Risk Assessment

Business risks include Tobacco demand, regulatory restrictions, excise-tax changes, packaging and marketing constraints, and illicit-trade dynamics can affect volumes, pricing power, and product mix., Currency movements and inflation in overseas tobacco markets can create a material divergence between reported yen earnings and management's currency-constant adjusted operating-income performance., The Canadian smoking-and-health litigation settlement arrangement creates an ongoing cash-flow and earnings-adjustment consideration, with potential implications for capital allocation., Reported DSO of 69 days is above the 60-day alert level; slower collections can extend the cash cycle and increase customer-credit exposure., Reported DIO of 250 days exceeds both the 90-day general warning level and the 60-day processed-goods threshold; this elevates inventory carrying-cost, valuation, and demand-forecast risk., A 180-day reported cash conversion cycle is above the 120-day warning level and makes operating cash flow more sensitive to working-capital movements..

Financial risks include OCF-to-net-income conversion of 0.77x is below the 0.8x alert threshold, indicating that accounting profit is not fully converting into operating cash flow., Goodwill of ¥2,986.7bn equals 67.5% of equity, above the 50% warning benchmark; any deterioration in acquired-business performance could result in impairment and a material reduction in book equity., Net finance costs were ¥38.9bn in the first half, as finance costs of ¥77.6bn exceeded finance income of ¥38.6bn; higher funding costs could pressure pre-tax earnings., The forecast dividend payout ratio of approximately 75% leaves less retained cash than a lower-payout policy, increasing dependence on stable operating cash generation..

Key concerns include Highest priority: normalize cash conversion, as receivables, inventories, payables, and other working capital consumed ¥244.6bn of cash in aggregate., Highest priority: protect acquired-business value, because goodwill represents 34.4% of assets and 67.5% of equity; the root cause is the large acquisition-related asset base, the context is a balance sheet dependent on sustained acquisition performance, and the impact is elevated impairment sensitivity., High priority: manage the long working-capital cycle. The root cause is elevated receivable and inventory days combined with reduced payable financing; the impact is weaker free-cash-flow headroom for dividends, debt service, and strategic investment., Medium priority: sustain price/mix and cost discipline. The current 282bp operating-margin expansion is strong, but tobacco regulation, tax changes, competitive intensity, and foreign-exchange volatility can affect its durability..

Investment Implications

Key takeaways include First-half operating performance was strong, with revenue up 17.7%, operating income up 29.0%, and profit attributable to owners up 35.0%., Margin quality improved materially: gross margin rose 130bp and operating margin rose 282bp, supported by SG&A growth below revenue growth., Annualized ROE of 19.5% and annualized ROA of approximately 10.1% indicate a high-return earnings model., First-half operating income and profit attributable to owners are ahead of the full-year run rate implied by the revised forecast., Cash conversion is the principal near-term financial quality issue, with OCF/net income at 0.77x and a 180-day reported cash conversion cycle., Goodwill concentration is the principal balance-sheet risk, at 67.5% of equity..

Metrics to watch include Currency-constant adjusted operating-income growth versus management's mid- to high-single-digit medium-term target., Second-half revenue, operating-income, and profit progress relative to the FY2026 forecast., Operating cash flow relative to net income, with improvement above 0.8x and ultimately toward 1.0x as the key quality objective., DSO, DIO, and the cash conversion cycle, particularly whether receivable and inventory cash absorption reverses., Goodwill impairment testing outcomes and the ratio of goodwill to equity., Cash payments and accounting adjustments associated with the Canadian litigation settlement., Free-cash-flow coverage of the ¥272 per-share annual dividend..

Regarding relative positioning, JT exhibits profitability that is strong by broad consumer-staples standards, with a 32.5% operating margin, 21.7% net margin, and 19.5% annualized ROE. Its balance sheet has adequate near-term liquidity and non-aggressive reported debt-to-equity, but its relative risk profile is elevated by a large goodwill position and a long reported working-capital cycle. The company should therefore be assessed primarily on the resilience of tobacco pricing and cash generation rather than on reported earnings growth alone.